TRIM8 modulates STAT3 activity through negative regulation of PIAS3

Journal of Cell Science

Volumn 123, Issue 13, 2010, Pages 2238-2245

  Okumura, Fumihiko ^a   Matsunaga, Yui ^a   Katayama, Yuta ^b,c   Nakayama, Keiichi I ^b,c   Hatakeyama, Shigetsugu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

IL 6; PIAS3; STAT3; TRIM8; Ubiquitin

Indexed keywords

INTERLEUKIN 6; PROTEASOME; PROTEIN DERIVATIVE; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT3; STAT3 PROTEIN; TRIPARTITE MOTIF PROTEIN 8; UBIQUITIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHAPERONE; NERVE PROTEIN; PIAS3 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; TRIM8 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL STRAIN 3T3; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; 3T3 CELL LINE; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; HELA CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; UBIQUITINATION;

ANIMALS; CARRIER PROTEINS; HELA CELLS; HUMANS; INTERLEUKIN-6; MICE; MOLECULAR CHAPERONES; NERVE TISSUE PROTEINS; NIH 3T3 CELLS; PROTEIN INHIBITORS OF ACTIVATED STAT; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITINATION;

EID: 77954364837     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.068981     Document Type: Article

References (48)

1. Alexander, W. S. (2002). Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2, 410-416. (Pubitemid 37328748)
2. Aravind, L. and Koonin, E. V. (2000). The U box is a modified RING finger-a common domain in ubiquitination. Curr. Biol. 10, R132-R134.
3. Boyapati, A., Yan, M., Peterson, L. F., Biggs, J. R., Le Beau, M. M. and Zhang, D. E. (2007). A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy. Blood 109, 3963-3971.
4. Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W. and Darnell, J. E., Jr (1998). Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18, 2553-2558.
5. Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C. and Darnell, J. E., Jr (1999). Stat3 as an oncogene. Cell 98, 295-303.
6. Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P. and Shuai, K. (1997). Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805.
7. Cyr, D. M., Hohfeld, J. and Patterson, C. (2002). Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem. Sci. 27, 368-375.
8. Darnell, J. E., Jr (1998). Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res. 18, 549-554.
9. Duval, D., Duval, G., Kedinger, C., Poch, O. and Boeuf, H. (2003). The 'PINIT' motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L. FEBS Lett. 554, 111-118.
10. Freemont, P. S. (2000). RING for destruction? Curr. Biol. 10, R84-R87.
11. Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N. and Nakayama, K. I. (2001). U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276, 33111-33120.
12. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G. and Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20.
13. Herrmann, A., Vogt, M., Monnigmann, M., Clahsen, T., Sommer, U., Haan, S., Poli, V., Heinrich, P. C. and Muller-Newen, G. (2007). Nucleocytoplasmic shuttling of persistently activated STAT3. J. Cell Sci. 120, 3249-3261.
14. Hershko, A. and Ciechanover, A. (1992). The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61, 761-807.
15. Hershko, A. and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
16. Horvath, C. M., Wen, Z. and Darnell, J. E., Jr (1995). A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9, 984-994.
17. Huang, S. (2007). Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin. Cancer Res. 13, 1362-1366.
18. Huibregtse, J. M., Scheffner, M., Beaudenon, S. and Howley, P. M. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92, 2563-2567.
19. Jang, H. D., Yoon, K., Shin, Y. J., Kim, J. and Lee, S. Y. (2004). PIAS3 suppresses NFkappaB- mediated transcription by interacting with the p65/RelA subunit. J. Biol. Chem. 279, 24873-24880.
20. Joazeiro, C. A. and Weissman, A. M. (2000). RING finger proteins: mediators of ubiquitin ligase activity. Cell 102, 549-552.
21. Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S. et al. (2001). The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276, 12530-12538.
22. Kano, S., Miyajima, N., Fukuda, S. and Hatakeyama, S. (2008). Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2. Cancer Res. 68, 5572-5580.
23. Kmiecik, T. E. and Shalloway, D. (1987). Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49, 65-73.
24. Kubo, M., Hanada, T. and Yoshimura, A. (2003). Suppressors of cytokine signaling and immunity. Nat. Immunol. 4, 1169-1176.
25. Lacronique, V., Boureux, A., Valle, V. D., Poirel, H., Quang, C. T., Mauchauffe, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J. et al. (1997). A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278, 1309-1312.
26. Levy, C., Nechushtan, H. and Razin, E. (2002). A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J. Biol. Chem. 277, 1962-1966.
27. Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S. and Weissman, A. M. (1999). RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96, 11364-11369.
28. Meroni, G. and Diez-Roux, G. (2005). TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. BioEssays 27, 1147-1157.
29. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M. and Hirano, T. (1996). A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15, 3651-3658.
30. Nisole, S., Stoye, J. P. and Saib, A. (2005). TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3, 799-808.
31. Okumura, F., Hatakeyama, S., Matsumoto, M., Kamura, T. and Nakayama, K. I. (2004). Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B contributes to neuritogenesis. J. Biol. Chem. 279, 53533-53543.
32. Okumura, F., Zou, W. and Zhang, D. E. (2007). ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev. 21, 255-260.
33. Peters, J. M. (1998). SCF and APC: the Yin and Yang of cell cycle regulated proteolysis. Curr. Opin. Cell Biol. 10, 759-768.
34. Peterson, L. F., Boyapati, A., Ahn, E. Y., Biggs, J. R., Okumura, A. J., Lo, M. C., Yan, M. and Zhang, D. E. (2007). Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. Blood 110, 799-805.
35. Rajsbaum, R., Stoye, J. P. and O'Garra, A. (2008). Type I interferon-dependent and - independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 38, 619-630.
36. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S. et al. (2001). The tripartite motif family identifies cell compartments. EMBO J. 20, 2140-2151.
37. Scheffner, M., Nuber, U. and Huibregtse, J. M. (1995). Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81-83.
38. Schwaller, J., Frantsve, J., Aster, J., Williams, I. R., Tomasson, M. H., Ross, T. S., Peeters, P., Van Rompaey, L., Van Etten, R. A., Ilaria, R., Jr et al. (1998). Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J. 17, 5321-5333.
39. Sentis, S., Le Romancer, M., Bianchin, C., Rostan, M. C. and Corbo, L. (2005). Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol. Endocrinol. 19, 2671-2684.
40. Shuai, K. and Liu, B. (2005). Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5, 593-605. (Pubitemid 41113191)
41. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. and Schreiber, R. D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
42. Toniato, E., Chen, X. P., Losman, J., Flati, V., Donahue, L. and Rothman, P. (2002). TRIM8/GERP RING finger protein interacts with SOCS-1. J. Biol. Chem. 277, 37315-37322.
43. Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P. and Jove, R. (1998). Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18, 2545-2552.
44. Vincent, S. R., Kwasnicka, D. A. and Fretier, P. (2000). A novel RING finger-B box-coiled-coil protein, GERP. Biochem. Biophys. Res. Commun. 279, 482-486.
45. Wegenka, U. M., Buschmann, J., Lutticken, C., Heinrich, P. C. and Horn, F. (1993). Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13, 276-288.
46. Yagil, Z., Kay, G., Nechushtan, H. and Razin, E. (2009). A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells. J. Immunol. 182, 2168-2175.
47. Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J. and Jove, R. (1995). Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83.
48. Yu, H., Kortylewski, M. and Pardoll, D. (2007). Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7, 41-51. (Pubitemid 46020826)